Sanofi Says it does not intend to make an offer for horizon, leaving Amgen as sole bidder

(Reuters) -French health group Sanofi said on Sunday that it no longer intends to make an offer for biotech company Horizon Therapeutics Plc , leaving Amgen Inc as the only remaining bidder.

The Wall Street Journal reported on Sunday that Amgen was in advanced talks to buy Horizon. A deal could be finalised by Monday assuming the talks with Amgen don’t fall apart, the report added.

(Reporting by Kanjyik Ghosh in BengaluruEditing by Peter Graff)